What Our Own Cancer Research Suggests
A continually updated collection of research, clinical evidence, treatment questions, safety considerations, and expert perspectives on ivermectin and fenbendazole in cancer care.
Ivermectin and fenbendazole are both approved antiparasitic drugs that have drawn public attention as possible repurposed cancer treatments, largely through viral patient stories and early laboratory research. CAC does not claim either drug cures cancer. What we do is investigate the evidence as it stands, track it as new research and clinical trials emerge, and separate documented findings from anecdote and marketing claims. This page organizes everything CAC has published on both compounds in one place.
Table of Contents
- Ivermectin & Cancer
- Fenbendazole & Cancer
- Combining Ivermectin, Fenbendazole & Mebendazole
- From Promise to Proof: What Science Really Says About Ivermectin and Mebendazole in Cancer Treatment
- Combining Ivermectin & Mebendazole with Standard Cancer Therapies
- Comprehensive Dosage Guide of Fenbendazole and Ivermectin for Humans
- The Wellness Company Study of Ivermectin and Mebendazole Review
- Fenbendazole vs. Mebendazole: Is There a Clinically Superior Benzimidazole for Colon Cancer?
- Before You Talk to Your Oncologist
- Taking The Next Step
- Donation
Ivermectin & Cancer
-
Breaking Down the Study Design: Why Observational and Self-Reported Data Have Serious Limits
Courage Against Cancer critiques the methodology of the Hulscher et al. study on cancer treatment, emphasizing the weaknesses of observational design and self-reported outcomes. It highlights issues like lack of randomization, potential bias, and conflicts of interest, stressing that results cannot reliably inform clinical decisions and urging patients to consult oncologists about research before acting.
-
Is Ivermectin approved by the FDA as a cancer treatment for any type of cancer?
As of 2026, the FDA has not approved ivermectin for any cancer treatments; it is only sanctioned for specific parasitic infections. While off-label prescribing is legal, there is no solid evidence supporting its efficacy in oncology. Patients should consult their healthcare providers before altering treatment plans based on unverified claims.
-
The Wellness Company Study of Ivermectin and Mebendazole Review
A study conducted by Dr. Nicolas Hulscher at the Wellness Company examined the effects of compounded Ivermectin and Menebedazole on 197 cancer patients over six months. While results appear promising, concerns arise regarding the study’s methodology, raising questions about the necessity of formal clinical trials for FDA consideration.
Fenbendazole & Cancer
-
The Bottom Line: Separating Hope From Evidence in the Fenbendazole Debate
At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the central question driving this conversation: Does fenbendazole have a legitimate role in colorectal cancer care? The honest answer in 2026 is nuanced ā early-stage laboratory findings are genuinely in…
-
Who Is Joe Tippens and Why Did His Fenbendazole Story Go Viral?
At Courage Against Cancer (CAC), we believe every patient deserves honest, compassionate information ā especially when a viral story raises life-altering questions. Joe Tippens is an Oklahoma businessman whose dramatic account ignited global interest in repurposed drugs and alternative cancer ap…
-
How Fenbendazole Compares to Mebendazole and Other Repurposed Antiparasitic Drugs in Oncology Research
At Courage Against Cancer (CAC), we believe patients deserve evidence-based answers to the pillar article primary question: Can repurposed antiparasitic drugs play a meaningful role in colorectal cancer research? Fenbendazole has generated significant public attention, but it isn’t the only benz…
Combining Ivermectin, Fenbendazole & Mebendazole
These three benzimidazole/antiparasitic compounds are frequently discussed together, sometimes as part of combined protocols. Here’s what’s been published on combining them and how they compare to each other.
-
The Bottom Line: Separating Hope From Evidence in the Fenbendazole Debate
At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the central question driving this conversation: Does fenbendazole have a legitimate role in colorectal cancer care? The honest answer in 2026 is nuanced ā early-stage laboratory findings are genuinely in…
-
Who Is Joe Tippens and Why Did His Fenbendazole Story Go Viral?
At Courage Against Cancer (CAC), we believe every patient deserves honest, compassionate information ā especially when a viral story raises life-altering questions. Joe Tippens is an Oklahoma businessman whose dramatic account ignited global interest in repurposed drugs and alternative cancer ap…
-
How Fenbendazole Compares to Mebendazole and Other Repurposed Antiparasitic Drugs in Oncology Research
At Courage Against Cancer (CAC), we believe patients deserve evidence-based answers to the pillar article primary question: Can repurposed antiparasitic drugs play a meaningful role in colorectal cancer research? Fenbendazole has generated significant public attention, but it isn’t the only benz…
Before You Talk to Your Oncologist
-
The Bottom Line: Separating Hope From Evidence in the Fenbendazole Debate
At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the central question driving this conversation: Does fenbendazole have a legitimate role in colorectal cancer care? The honest answer in 2026 is nuanced ā early-stage laboratory findings are genuinely in…
-
Who Is Joe Tippens and Why Did His Fenbendazole Story Go Viral?
At Courage Against Cancer (CAC), we believe every patient deserves honest, compassionate information ā especially when a viral story raises life-altering questions. Joe Tippens is an Oklahoma businessman whose dramatic account ignited global interest in repurposed drugs and alternative cancer ap…
-
How Fenbendazole Compares to Mebendazole and Other Repurposed Antiparasitic Drugs in Oncology Research
At Courage Against Cancer (CAC), we believe patients deserve evidence-based answers to the pillar article primary question: Can repurposed antiparasitic drugs play a meaningful role in colorectal cancer research? Fenbendazole has generated significant public attention, but it isn’t the only benz…
Taking The Next Step
Researching one specific treatment is often just the beginning. Many people looking into ivermectin or fenbendazole are also thinking about nutrition, metabolic health, and building a broader plan around their diagnosis. If that’s you, CAC’s Wellness Playbook takes a wider view of personalized coaching and testing rather than a single compound.
Explore your options…
CAC Wellness Playbook ->
Was this information useful?
CAC provides this research and education free to cancer patients and families. If it helped you, consider giving $5 to help us keep it free.
Make a monthly donation
Choose an amount
Or enter a custom amount
Your contribution is appreciated.
Stay Courageous. Healing is possible.
ā Courage Against Cancer